US Stock MarketDetailed Quotes

EGRX Eagle Pharmaceuticals

Watchlist
  • 5.720
  • -0.020-0.35%
Close Jul 26 16:00 ET
  • 5.630
  • -0.090-1.57%
Pre 07:55 ET
74.12MMarket Cap6.50P/E (TTM)

Eagle Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
Total revenue
-12.80%64.65M
-42.78%66.31M
84.56%316.61M
43.43%60.7M
65.36%65.9M
54.05%74.14M
180.91%115.87M
-8.66%171.55M
-15.22%42.32M
-20.18%39.85M
Operating revenue
-12.80%64.65M
-42.78%66.31M
84.56%316.61M
43.43%60.7M
65.36%65.9M
54.05%74.14M
180.91%115.87M
-8.66%171.55M
-15.22%42.32M
-20.18%39.85M
Cost of revenue
-28.76%16.86M
-37.67%17.3M
125.07%94.94M
61.39%19.87M
186.37%23.65M
119.99%23.66M
155.69%27.76M
-7.23%42.18M
-1.85%12.31M
-31.09%8.26M
Gross profit
-5.32%47.79M
-44.39%49.01M
71.35%221.67M
36.06%40.83M
33.73%42.25M
35.07%50.47M
189.92%88.12M
-9.11%129.37M
-19.70%30.01M
-16.73%31.59M
Operating expense
-22.34%37.48M
31.61%37.23M
11.15%140.71M
30.09%31.37M
-21.51%32.79M
81.82%48.27M
-17.20%28.29M
15.74%126.6M
-12.58%24.11M
85.44%41.77M
Selling and administrative expenses
-24.93%27.65M
26.05%27.96M
41.56%106.63M
18.82%24.15M
26.95%23.46M
121.40%36.83M
11.59%22.18M
-4.17%75.32M
11.76%20.33M
4.44%18.48M
Research and development costs
-14.02%9.83M
51.80%9.27M
-33.52%34.09M
90.57%7.22M
-59.96%9.33M
15.40%11.44M
-57.25%6.11M
66.56%51.28M
-59.69%3.79M
382.37%23.29M
Operating profit
367.73%10.3M
-80.32%11.77M
2,823.80%80.96M
60.47%9.47M
192.97%9.46M
-79.64%2.2M
1,685.71%59.83M
-91.60%2.77M
-39.76%5.9M
-166.01%-10.18M
Net non-operating interest income expense
-306.82%-1.25M
-515.09%-1.3M
-251.07%-3.77M
-623.04%-1.66M
-699.50%-1.59M
-18.92%-308K
45.22%-212K
46.65%-1.08M
41.48%-230K
55.08%-199K
Non-operating interest income
-20.08%195K
37.66%212K
-51.61%271K
----
----
49.69%244K
340.00%154K
-0.36%560K
725.00%165K
328.26%197K
Non-operating interest expense
162.32%1.45M
314.21%1.52M
147.40%4.05M
389.62%1.93M
301.77%1.59M
30.81%552K
-13.27%366K
-36.55%1.64M
-4.36%395K
-19.02%396K
Other net income (expense)
103.18%247K
87.84%-238K
-152.37%-15.75M
223.76%5.5M
-404.99%-11.53M
-54.86%-7.76M
-135.58%-1.96M
24.45%-6.24M
-323.70%-4.45M
62.24%-2.28M
Other non- operating income (expenses)
103.18%247K
87.84%-238K
-152.37%-15.75M
223.76%5.5M
-404.99%-11.53M
-54.86%-7.76M
-135.58%-1.96M
24.45%-6.24M
-323.70%-4.45M
62.24%-2.28M
Income before tax
258.45%9.3M
-82.26%10.23M
1,450.77%61.43M
986.93%13.3M
71.07%-3.66M
-205.77%-5.87M
4,202.99%57.66M
-120.06%-4.55M
-89.25%1.22M
-241.85%-12.66M
Income tax
15.41%4.13M
-67.06%4.48M
532.29%25.79M
-30.74%5.14M
149.28%3.47M
85.02%3.58M
672.40%13.6M
-61.84%4.08M
122.82%7.42M
-477.17%-7.04M
Net income
154.65%5.16M
-86.95%5.75M
513.14%35.64M
231.78%8.17M
-26.84%-7.13M
-361.63%-9.45M
10,565.08%44.06M
-171.96%-8.63M
-176.90%-6.2M
-179.64%-5.62M
Net income continuous Operations
154.65%5.16M
-86.95%5.75M
513.14%35.64M
231.78%8.17M
-26.84%-7.13M
-361.63%-9.45M
10,565.08%44.06M
-171.96%-8.63M
-176.90%-6.2M
-179.64%-5.62M
Minority interest income
Net income attributable to the parent company
154.65%5.16M
-86.95%5.75M
513.14%35.64M
231.78%8.17M
-26.84%-7.13M
-361.63%-9.45M
10,565.08%44.06M
-171.96%-8.63M
-176.90%-6.2M
-179.64%-5.62M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
154.65%5.16M
-86.95%5.75M
513.14%35.64M
231.78%8.17M
-26.84%-7.13M
-361.63%-9.45M
10,565.08%44.06M
-171.96%-8.63M
-176.90%-6.2M
-179.64%-5.62M
Basic earnings per share
152.70%0.39
-87.32%0.44
518.18%2.76
231.25%0.63
-25.58%-0.54
-364.29%-0.74
11,666.67%3.47
-174.16%-0.66
-180.00%-0.48
-182.69%-0.43
Diluted earnings per share
152.70%0.39
-87.10%0.44
513.64%2.73
229.17%0.62
-25.58%-0.54
-374.07%-0.74
11,466.67%3.41
-175.86%-0.66
-181.36%-0.48
-184.31%-0.43
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021
Total revenue -12.80%64.65M-42.78%66.31M84.56%316.61M43.43%60.7M65.36%65.9M54.05%74.14M180.91%115.87M-8.66%171.55M-15.22%42.32M-20.18%39.85M
Operating revenue -12.80%64.65M-42.78%66.31M84.56%316.61M43.43%60.7M65.36%65.9M54.05%74.14M180.91%115.87M-8.66%171.55M-15.22%42.32M-20.18%39.85M
Cost of revenue -28.76%16.86M-37.67%17.3M125.07%94.94M61.39%19.87M186.37%23.65M119.99%23.66M155.69%27.76M-7.23%42.18M-1.85%12.31M-31.09%8.26M
Gross profit -5.32%47.79M-44.39%49.01M71.35%221.67M36.06%40.83M33.73%42.25M35.07%50.47M189.92%88.12M-9.11%129.37M-19.70%30.01M-16.73%31.59M
Operating expense -22.34%37.48M31.61%37.23M11.15%140.71M30.09%31.37M-21.51%32.79M81.82%48.27M-17.20%28.29M15.74%126.6M-12.58%24.11M85.44%41.77M
Selling and administrative expenses -24.93%27.65M26.05%27.96M41.56%106.63M18.82%24.15M26.95%23.46M121.40%36.83M11.59%22.18M-4.17%75.32M11.76%20.33M4.44%18.48M
Research and development costs -14.02%9.83M51.80%9.27M-33.52%34.09M90.57%7.22M-59.96%9.33M15.40%11.44M-57.25%6.11M66.56%51.28M-59.69%3.79M382.37%23.29M
Operating profit 367.73%10.3M-80.32%11.77M2,823.80%80.96M60.47%9.47M192.97%9.46M-79.64%2.2M1,685.71%59.83M-91.60%2.77M-39.76%5.9M-166.01%-10.18M
Net non-operating interest income expense -306.82%-1.25M-515.09%-1.3M-251.07%-3.77M-623.04%-1.66M-699.50%-1.59M-18.92%-308K45.22%-212K46.65%-1.08M41.48%-230K55.08%-199K
Non-operating interest income -20.08%195K37.66%212K-51.61%271K--------49.69%244K340.00%154K-0.36%560K725.00%165K328.26%197K
Non-operating interest expense 162.32%1.45M314.21%1.52M147.40%4.05M389.62%1.93M301.77%1.59M30.81%552K-13.27%366K-36.55%1.64M-4.36%395K-19.02%396K
Other net income (expense) 103.18%247K87.84%-238K-152.37%-15.75M223.76%5.5M-404.99%-11.53M-54.86%-7.76M-135.58%-1.96M24.45%-6.24M-323.70%-4.45M62.24%-2.28M
Other non- operating income (expenses) 103.18%247K87.84%-238K-152.37%-15.75M223.76%5.5M-404.99%-11.53M-54.86%-7.76M-135.58%-1.96M24.45%-6.24M-323.70%-4.45M62.24%-2.28M
Income before tax 258.45%9.3M-82.26%10.23M1,450.77%61.43M986.93%13.3M71.07%-3.66M-205.77%-5.87M4,202.99%57.66M-120.06%-4.55M-89.25%1.22M-241.85%-12.66M
Income tax 15.41%4.13M-67.06%4.48M532.29%25.79M-30.74%5.14M149.28%3.47M85.02%3.58M672.40%13.6M-61.84%4.08M122.82%7.42M-477.17%-7.04M
Net income 154.65%5.16M-86.95%5.75M513.14%35.64M231.78%8.17M-26.84%-7.13M-361.63%-9.45M10,565.08%44.06M-171.96%-8.63M-176.90%-6.2M-179.64%-5.62M
Net income continuous Operations 154.65%5.16M-86.95%5.75M513.14%35.64M231.78%8.17M-26.84%-7.13M-361.63%-9.45M10,565.08%44.06M-171.96%-8.63M-176.90%-6.2M-179.64%-5.62M
Minority interest income
Net income attributable to the parent company 154.65%5.16M-86.95%5.75M513.14%35.64M231.78%8.17M-26.84%-7.13M-361.63%-9.45M10,565.08%44.06M-171.96%-8.63M-176.90%-6.2M-179.64%-5.62M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 154.65%5.16M-86.95%5.75M513.14%35.64M231.78%8.17M-26.84%-7.13M-361.63%-9.45M10,565.08%44.06M-171.96%-8.63M-176.90%-6.2M-179.64%-5.62M
Basic earnings per share 152.70%0.39-87.32%0.44518.18%2.76231.25%0.63-25.58%-0.54-364.29%-0.7411,666.67%3.47-174.16%-0.66-180.00%-0.48-182.69%-0.43
Diluted earnings per share 152.70%0.39-87.10%0.44513.64%2.73229.17%0.62-25.58%-0.54-374.07%-0.7411,466.67%3.41-175.86%-0.66-181.36%-0.48-184.31%-0.43
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --------------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg